HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ludovic Desvignes Selected Research

lufotrelvir

2/2021A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
2/2021A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ludovic Desvignes Research Topics

Disease

6COVID-19
10/2021 - 02/2021
5Tuberculosis (Tuberculoses)
08/2022 - 09/2007
4Infections
08/2021 - 06/2012
3Critical Illness (Critically Ill)
10/2021 - 02/2021
3Inflammation (Inflammations)
08/2021 - 12/2009
2Respiratory Insufficiency (Respiratory Failure)
03/2021 - 02/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2021
1Persistent Infection
06/2015

Drug/Important Bio-Agent (IBA)

3AntigensIBA
08/2022 - 10/2018
2VaccinesIBA
08/2022 - 08/2021
2Biomarkers (Surrogate Marker)IBA
03/2021 - 02/2021
2remdesivirIBA
02/2021 - 02/2021
2lufotrelvirIBA
02/2021 - 02/2021
2Antiviral Agents (Antivirals)IBA
02/2021 - 02/2021
1mRNA VaccinesIBA
08/2021
1InterferonsIBA
08/2021
1BNT162 VaccineIBA
08/2021
1Biological ProductsIBA
01/2020
1Peptides (Polypeptides)IBA
10/2018
1EpitopesIBA
10/2018
1Antigen-Antibody Complex (Immune Complex)IBA
06/2015
1Stromal Interaction Molecule 1IBA
06/2015
1AerosolsIBA
06/2012
1Interleukin-17 (Interleukin 17)IBA
12/2009
1Interleukin-6 (Interleukin 6)IBA
09/2007
1Peptidoglycan (Murein)IBA
09/2007

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
10/2021 - 02/2021